Re:Trials avoid high risk patients and underestimate drug harms
by ryanmcbride on Tuesday December 09, 2025 @11:00AM
(#46206432)
It's nowhere near my industry and I know virtually nothing about what really goes into these sorts of things, but seems like maybe whichever organization is doing the rankings should simply make that a negative metric. Like, a super negative metric.
[ Parent
| on HN ]
There are no comments on this comment yet.